# FDA Inspection 1177788 - Gipsco Investment Corp - July 22, 2022

Source: https://www.keypedia.com/records/fda_inspections/gipsco-investment-corp/72d486e0-a1d6-4e36-a407-eac777716eb1
Source feed: FDA_Inspections

> FDA Inspection 1177788 for Gipsco Investment Corp on July 22, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1177788
- Company Name: Gipsco Investment Corp
- Inspection Date: 2022-07-22
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1103566 - 2019-08-29](https://www.keypedia.com/records/fda_inspections/gipsco-investment-corp/71b320cb-6f3f-4a06-b0f8-acd837844558)
- [FDA Inspection 1014135 - 2017-06-09](https://www.keypedia.com/records/fda_inspections/gipsco-investment-corp/57dc9d90-8c35-46db-87a3-fb02627c88d9)

Company: https://www.keypedia.com/companies/gipsco-investment-corp/29265f19-8c03-46da-97aa-fd3ea30c57a9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c